ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Kovack Advisors Inc.

Kovack Advisors Inc. trimmed its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 7.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,109 shares of the company’s stock after selling 1,023 shares during the quarter. Kovack Advisors Inc.’s holdings in ARK Genomic Revolution ETF were worth $310,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of ARKG. Main Management ETF Advisors LLC increased its position in shares of ARK Genomic Revolution ETF by 2.3% in the 2nd quarter. Main Management ETF Advisors LLC now owns 2,754,610 shares of the company’s stock valued at $64,678,000 after purchasing an additional 62,470 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in ARK Genomic Revolution ETF by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after buying an additional 3,341 shares in the last quarter. Cetera Investment Advisers raised its stake in ARK Genomic Revolution ETF by 290.7% in the first quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock valued at $4,052,000 after buying an additional 104,831 shares in the last quarter. Prudential PLC lifted its holdings in ARK Genomic Revolution ETF by 15.0% during the 2nd quarter. Prudential PLC now owns 140,170 shares of the company’s stock worth $3,326,000 after buying an additional 18,300 shares during the last quarter. Finally, SG Americas Securities LLC boosted its position in shares of ARK Genomic Revolution ETF by 5.4% during the 2nd quarter. SG Americas Securities LLC now owns 129,356 shares of the company’s stock worth $3,037,000 after acquiring an additional 6,675 shares in the last quarter.

ARK Genomic Revolution ETF Trading Down 6.1 %

Shares of BATS ARKG opened at $22.66 on Friday. The stock’s fifty day simple moving average is $24.88 and its 200-day simple moving average is $25.15.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.